首页> 美国卫生研究院文献>Journal of Clinical Medicine >Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay

【2h】

Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay

机译：校正对英夫利昔单抗和贲高单抗监测结果的临床影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Journal of Clinical Medicine
作者
Konstantinos Papamichael; Valerio J. Thomas; Andrea Banty; William T. Clarke; Katharine A. Germansky; Sarah N. Flier; Joseph D. Feuerstein; Gil Y. Melmed; Adam S. Cheifetz;
展开▼
作者单位

展开▼
年(卷),期 2020(9),9
年度 2020
页码 2840
总页数 9
原文格式 PDF
正文语种
中图分类
关键词
anti-TNF therapy; therapeutic drug monitoring; homogenous mobility shift assay; inflammatory bowel disease;

机译：抗TNF疗法;治疗药物监测;均匀的迁移率转变测定;炎症性肠病;

相似文献

外文文献
中文文献
专利

1. Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study [J] . Clarke William T., Papamichael Konstantinos, Vande Casteele Niels, Inflammatory bowel diseases . 2019,第11期

机译：英夫利昔单抗和阿巴木单抗浓度可在酶联免疫吸附测定和炎症性肠病患者中的均匀迁移率移位测定之间变化：一个潜在的横截面观察研究
2. Discrimination of Anti-drug Antibodies With Neutralizing Capacity in Infliximab-and Adalimumab-Treated Patients: Comparison of the Homogeneous Mobility Shift Assay and the Affinity Capture and Elution Assay [J] . Hock Barry D., McKenzie Judith L., Goddard Liping, Therapeutic Drug Monitoring . 2018,第6期

机译：inciximab-and Adalimalab治疗患者中和能力的抗药抗体的辨别：均匀迁移率移位测定和亲和捕获和洗脱测定的比较
3. Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay [J] . WangS.-L., HauensteinS., OhrmundL., Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis . 2013,第Null期

机译：通过均质迁移率变动分析监测患者血清中的阿达木单抗和抗体对阿达木单抗的水平
4. Quantum dot electrophoretic mobility shift assay and its application to the measurement of exonuclease activity [C] . Zhang Yi, Wang Tza-Huei 2012 12th IEEE International Conference on Nanotechnology. . 2012

机译：量子点电泳迁移率变动分析及其在核酸外切酶活性测量中的应用
5. The use of a secreted embryonic alkaline phosphatase-based reporter plasmid assay and electrophoretic mobility shift assays to investigate differences in signal transduction between a chemosensitive cell line (MCF-7) and two chemoresistant cell lines (MCF-7TAX> and MCF-7DOX) . [D] . Dew, William Albert. 2006

机译：使用分泌的基于胚胎碱性磷酸酶的报道分子质粒测定法和电泳迁移率变动测定法研究化学敏感性细胞系（MCF-7）和两种化学抗性细胞系（MCF-7TAX>和MCF-7DOX）之间信号转导的差异。
6. Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab etanercept or infliximab: Results from a multinational real-world clinical practice non-interventional study [O] . Robert J. Moots, Ricardo M. Xavier, Chi Chiu Mok, -1

机译：校正：抗药物抗体对使用阿达木单抗依那西普或英夫利昔单抗治疗的类风湿关节炎患者的药物浓度和临床结局的影响：一项来自跨国真实世界的临床实践的非干预性研究结果
7. Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay [O] . Konstantinos Papamichael, Valerio J. Thomas, Andrea Banty, 2020

机译：校正对英夫利昔单抗和贲高单抗监测结果的临床影响与均匀迁移率移位测定

Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay

著录项

相似文献

相关主题

期刊订阅